Literature DB >> 16585446

Body image and attitudes toward male roles in anabolic-androgenic steroid users.

Gen Kanayama1, Steven Barry, James I Hudson, Harrison G Pope.   

Abstract

OBJECTIVE: The authors sought to expand on previous observations suggesting that body-image pathology is associated with illicit use of anabolic-androgenic steroids (AAS). In particular, the authors compared current versus past AAS users and short-term versus long-term users in this respect.
METHOD: The authors assessed 89 heterosexual men who lifted weights regularly-48 AAS users and 41 nonusers-on measures of self-esteem, attitudes toward male roles, body image, eating-related attitudes and behaviors, and muscle dysmorphia ("reverse anorexia nervosa").
RESULTS: AAS users as a whole showed few differences from nonusers on most measures but showed greater symptoms of muscle dysmorphia (e.g., not allowing their bodies to be seen in public, giving up pleasurable activities because of body-appearance concerns). The current and past AAS users each differed only modestly from nonusers on most measures. Short-term AAS "experimenters" were also largely indistinguishable from nonusers, but the long-term AAS users showed striking and significant differences from nonusers on many measures, including marked symptoms of muscle dysmorphia and stronger endorsement of conventional male roles.
CONCLUSIONS: Both body-image pathology and narrow stereotypic views of masculinity appear to be prominent among men with long-term AAS use. Although our cross-sectional observations cannot confirm that these factors help to cause or perpetuate AAS use, a causal hypothesis is certainly plausible and deserving of further testing in longitudinal studies. If these factors are indeed causal, then AAS users might respond to cognitive behavior approaches that simultaneously take aim at both types of maladaptive beliefs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585446     DOI: 10.1176/ajp.2006.163.4.697

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   19.242


  29 in total

1.  Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson
Journal:  Biol Psychiatry       Date:  2011-08-12       Impact factor: 13.382

Review 2.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

3.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

Review 4.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

5.  Can we consider religiousness as a protective factor against doping behavior in sport?

Authors:  Jelena Rodek; Damir Sekulic; Emir Pasalic
Journal:  J Relig Health       Date:  2008-09-26

6.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

7.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

Review 8.  Muscle Dysmorphia Symptomatology and Associated Psychological Features in Bodybuilders and Non-Bodybuilder Resistance Trainers: A Systematic Review and Meta-Analysis.

Authors:  Lachlan Mitchell; Stuart B Murray; Stephen Cobley; Daniel Hackett; Janelle Gifford; Louise Capling; Helen O'Connor
Journal:  Sports Med       Date:  2017-02       Impact factor: 11.136

Review 9.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

10.  Clinical features of muscle dysmorphia among males with body dysmorphic disorder.

Authors:  Courtney G Pope; Harrison G Pope; William Menard; Christina Fay; Roberto Olivardia; Katharine A Phillips
Journal:  Body Image       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.